FY2025 EPS Estimates for RCKT Lifted by Cantor Fitzgerald
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Equities researchers at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for shares of Rocket Pharmaceuticals in a research report issued to clients and investors on Monday, May 12th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the biotechnology company will post earnings per share […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Equities researchers at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for shares of Rocket Pharmaceuticals in a research report issued to clients and investors on Monday, May 12th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the biotechnology company will post earnings per share […]
